Abstract |
The cytotoxicity of hexamethylmelamine (HMM) and its metabolites pentamethylmelamine (PMM), N,2,2,4,6-tetramethylmelamine (TMM) and hydroxymethylpentamethylmelamine (HMPMM) and of the alkylating agent triethylenemelamine (TEM) were studied on a cell line derived from a human ovarian cancer, by measuring [3H]TdR uptake. After 24 h of incubation all the tested compounds inhibited [3H]TdR uptake, but only at a concentration of 100 micrograms/ml. However, after 120 h incubation, concentrations of 0.1--10 micrograms/ml resulted in highly significant cytotoxicity. HMPMM and TEM were the most active and their effect was not reversed 72 h after their removal. In our in vitro system no metabolism of HMM was observed.
|
Authors | M D'Incalci, E Erba, G Balconi, L Morasca, S Garattini |
Journal | British journal of cancer
(Br J Cancer)
Vol. 41
Issue 4
Pg. 630-5
(Apr 1980)
ISSN: 0007-0920 [Print] England |
PMID | 6770884
(Publication Type: Journal Article)
|
Chemical References |
- Triazines
- Altretamine
- Thymidine
|
Topics |
- Altretamine
(metabolism, pharmacology)
- Cell Line
- Cells
(drug effects, metabolism)
- Female
- Humans
- Ovarian Neoplasms
(pathology)
- Thymidine
(metabolism)
- Time Factors
- Triazines
(pharmacology)
|